{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T01:09:26Z","timestamp":1772327366796,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.acuroe.2026.501918","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T16:52:20Z","timestamp":1767631940000},"page":"501918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of focal therapy for localized prostate cancer: From diagnosis to ablation"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2222-027X","authenticated-orcid":false,"given":"R.","family":"Roldan-Testillano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Rodriguez-Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.","family":"Rodr\u00edguez Socarr\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"de Andr\u00e9s Boville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Durazo-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"G\u00f3mez Rivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Alfambra Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"S\u00e1nchez Mac\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.J.","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mi\u00f1ana L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Sanchez-Salas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.acuroe.2026.501918_bib0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eururo.2021.08.005","article-title":"An updated systematic review on focal therapy in localized prostate cancer: what has changed over the past 5 years?","volume":"81","author":"Hopstaken","year":"2022","journal-title":"Eur Urol"},{"issue":"10071","key":"10.1016\/j.acuroe.2026.501918_bib0010","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.acuroe.2026.501918_bib0015","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1001\/jama.2025.3579","article-title":"Microultrasonography-guided vs MRI-guided biopsy for prostate cancer diagnosis: the OPTIMUM randomized clinical trial","volume":"333","author":"Kinnaird","year":"2025","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.acuroe.2026.501918_bib0020","first-page":"1644","article-title":"The PRIMARY score: using intraprostatic 68Ga-PSMA PET\/CT patterns to optimize prostate cancer diagnosis","volume":"63","author":"Emmett","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.acuroe.2026.501918_bib0025","unstructured":"Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica. Las cifras del c\u00e1ncer en Espa\u00f1a 2024 [Internet]. 2024 [accessed 10 Dec 2024]. Available from: https:\/\/www.seom.org\/images\/LAS_CIFRAS_2024.pdf."},{"key":"10.1016\/j.acuroe.2026.501918_bib0030","doi-asserted-by":"crossref","unstructured":"Klotz L. 3rd WUOF\/SIU ICUD on localized prostate cancer. Committee 13: Focal therapy\u2014principles and outcomes [Internet]. 2024 [accessed 10 Dec 2024]. Available from: https:\/\/www.siu-urology.org\/themes\/web\/assets\/files\/3rd-wuof-siu-icud-localized-prostate-cancer-final4.pdf.","DOI":"10.3390\/siuj6030047"},{"issue":"11","key":"10.1016\/j.acuroe.2026.501918_bib0035","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.21037\/tcr-23-2406","article-title":"A narrative clinical trials review in the realm of focal therapy for localized prostate cancer","volume":"13","author":"Lazarovich","year":"2024","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.acuroe.2026.501918_bib0040","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMcibr0905562","article-title":"The index lesion and the origin of prostate cancer","volume":"361","author":"Ahmed","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.acuroe.2026.501918_bib0045","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1590\/s1677-5538.ibju.2019.05.02","article-title":"Focal therapy for prostate cancer \u2013 index lesion treatment vs hemiablation: a matter of definition","volume":"45","author":"Stabile","year":"2019","journal-title":"Int Braz J Urol"},{"issue":"4 Suppl","key":"10.1016\/j.acuroe.2026.501918_bib0050","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0022-5347(18)33766-2","article-title":"Is focal therapy reasonable in patients with early stage prostate cancer: an analysis of radical prostatectomy specimens","volume":"175","author":"Ohori","year":"2006","journal-title":"J Urol"},{"issue":"7","key":"10.1016\/j.acuroe.2026.501918_bib0055","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1200\/JCO.20.02873","article-title":"Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized phase III trial","volume":"39","author":"Kerkmeijer","year":"2021","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.acuroe.2026.501918_bib0060","first-page":"343","article-title":"Effect of focal vs extended irreversible electroporation for the ablation of localized low- or intermediate-risk prostate cancer on early oncological control: a randomized clinical trial","volume":"158","author":"Zhang","year":"2023","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.acuroe.2026.501918_bib0065","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/ijc.34743","article-title":"Histomic and transcriptomic features of MRI-visible and invisible clinically significant prostate cancers are associated with prognosis","volume":"154","author":"Lehto","year":"2023","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.acuroe.2026.501918_bib0070","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1910038","article-title":"MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis","volume":"382","author":"Ahdoot","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.acuroe.2026.501918_bib0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eururo.2023.12.015","article-title":"Transperineal versus transrectal magnetic resonance imaging\u2013targeted and systematic prostate biopsy to prevent infectious complications: the PREVENT randomized trial","volume":"86","author":"Hu","year":"2024","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.acuroe.2026.501918_bib0080","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.euo.2024.01.019","article-title":"Transperineal versus transrectal magnetic resonance imaging\u2013targeted biopsies for prostate cancer diagnosis: final results of the randomized PERFECT trial (CCAFU-PR1)","volume":"7","author":"Ploussard","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"10.1016\/j.acuroe.2026.501918_bib0085","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1470-2045(25)00100-7","article-title":"Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trial","volume":"26","author":"Bryant","year":"2025","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.acuroe.2026.501918_bib0090","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2022.01.008","article-title":"Targeted prostate biopsy: umbra, penumbra, and value of perilesional sampling","volume":"82","author":"Brisbane","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2026.501918_bib0095","article-title":"Micro-ultrasound: current role in prostate cancer diagnosis and future possibilities","volume":"15","author":"Dias","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.acuroe.2026.501918_bib0100","doi-asserted-by":"crossref","DOI":"10.1002\/bco2.456","article-title":"Focal therapy of prostate cancer: use of artificial intelligence to define tumour volume and predict treatment outcomes","volume":"6","author":"Brisbane","year":"2024","journal-title":"BJUI Compass"},{"issue":"7","key":"10.1016\/j.acuroe.2026.501918_bib0105","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S1470-2045(24)00220-1","article-title":"Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study","volume":"25","author":"Saha","year":"2024","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.acuroe.2026.501918_bib0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/bju.16360","article-title":"The FocAL therapy CONsensus (FALCON): enhancing partial gland ablation for localised prostate cancer","volume":"134","author":"Rodr\u00edguez-S\u00e1nchez","year":"2024","journal-title":"BJU Int"},{"key":"10.1016\/j.acuroe.2026.501918_bib0115","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer 2025","author":"Cornford","year":"2025","journal-title":"Eur Assoc Urol"},{"issue":"3","key":"10.1016\/j.acuroe.2026.501918_bib0120","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/bju.15739","article-title":"Functional and quality of life outcomes of localised Prostate Cancer Treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)","volume":"130","author":"Lane","year":"2022","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.acuroe.2026.501918_bib0125","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000502553","article-title":"Oncological outcome and value of postoperative magnetic resonance imaging after focal high-intensity focused ultrasound therapy for prostate cancer","volume":"103","author":"Rosenhammer","year":"2019","journal-title":"Int Urol"},{"issue":"6","key":"10.1016\/j.acuroe.2026.501918_bib0130","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.euo.2025.02.003","article-title":"Outcomes of focal therapy for localized prostate cancer: a systematic review and meta-analysis of prospective studies","volume":"8","author":"\u015alusarczyk","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.acuroe.2026.501918_bib0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.urology.2023.01.024","article-title":"Real-world comparative safety and effectiveness of irreversible electroporation and high-intensity focused ultrasound for prostate cancer ablation","volume":"174","author":"Cribbs","year":"2023","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.acuroe.2026.501918_bib0140","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41391-023-00699-7","article-title":"Oncological results and cancer control definition in focal therapy for prostate cancer: a systematic review","volume":"27","author":"Nicoletti","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"4","key":"10.1016\/j.acuroe.2026.501918_bib0145","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41391-023-00698-8","article-title":"Functional outcomes and safety of focal therapy for prostate cancer: a systematic review on results and patient-reported outcome measures (PROMs)","volume":"27","author":"Nicoletti","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1016\/j.acuroe.2026.501918_bib0150","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1590\/s1677-5538.ibju.2021.0091","article-title":"Available evidence on HIFU for focal treatment of prostate cancer: a systematic review","volume":"48","author":"Bakavicius","year":"2022","journal-title":"Int Braz J Urol"},{"issue":"12","key":"10.1016\/j.acuroe.2026.501918_bib0155","doi-asserted-by":"crossref","first-page":"449.e1","DOI":"10.1016\/j.urolonc.2024.08.011","article-title":"Salvage local treatment for recurrent prostate cancer after focal therapy: a systematic review and meta-analysis","volume":"42","author":"Takemura","year":"2024","journal-title":"Urol Oncol"},{"issue":"2","key":"10.1016\/j.acuroe.2026.501918_bib0160","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/bju.16496","article-title":"Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti-tumour T-cell activation \u2013 IRE-IMMUNO study","volume":"135","author":"Geboers","year":"2025","journal-title":"BJU Int"},{"key":"10.1016\/j.acuroe.2026.501918_bib0165","doi-asserted-by":"crossref","first-page":"118","DOI":"10.21037\/atm.2016.01.32","article-title":"Radiation therapy and the abscopal effect: a concept comes of age","volume":"4","author":"Ng","year":"2016","journal-title":"Ann Transl Med"},{"issue":"4","key":"10.1016\/j.acuroe.2026.501918_bib0170","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009794","article-title":"Irreversible electroporation synergizes with oncolytic virus enhances the infiltration of cytotoxic T lymphocytes in the tumor immune microenvironment: a leap from focal therapy to immunotherapy for prostate cancer","volume":"13","author":"Xia","year":"2025","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.acuroe.2026.501918_bib0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.omto.2023.04.007","article-title":"New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer","volume":"29","author":"Lin","year":"2023","journal-title":"Mol Ther Oncolytics"},{"issue":"8","key":"10.1016\/j.acuroe.2026.501918_bib0180","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3390\/cancers17081337","article-title":"Surveillance after focal therapy for prostate cancer: a comprehensive review","volume":"17","author":"Koehler","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.acuroe.2026.501918_bib0185","doi-asserted-by":"crossref","DOI":"10.1148\/rycan.240269","article-title":"Multiparametric MRI before and after focal therapy for prostate cancer: pearls and pitfalls for the reporting radiologist","volume":"7","author":"Lai","year":"2025","journal-title":"Radiol Imaging Cancer"},{"issue":"6","key":"10.1016\/j.acuroe.2026.501918_bib0190","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.euo.2023.04.007","article-title":"Prostate imaging after focal ablation (PI-FAB): a proposal for a scoring system for multiparametric MRI of the prostate after focal therapy","volume":"6","author":"Giganti","year":"2023","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"10.1016\/j.acuroe.2026.501918_bib0195","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2024.02.001","article-title":"The transatlantic recommendations for prostate gland evaluation with magnetic resonance imaging after focal therapy (TARGET): a systematic review and international consensus recommendations","volume":"85","author":"Light","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2026.501918_bib0200","article-title":"Is there a role of PSMA-PET in focal therapy planning and follow-up?","author":"Nicoletti","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.acuroe.2026.501918_bib0205","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/JU.0000000000002970","article-title":"Focal therapy of prostate cancer index lesion with irreversible electroporation: a prospective study with a median follow-up of 3 years","volume":"209","author":"Mi\u00f1ana L\u00f3pez","year":"2023","journal-title":"J Urol"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217357862600017X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217357862600017X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:38:40Z","timestamp":1772325520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S217357862600017X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S217357862600017X"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2026.501918","relation":{},"ISSN":["2173-5786"],"issn-type":[{"value":"2173-5786","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of focal therapy for localized prostate cancer: From diagnosis to ablation","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2026.501918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2025.501918","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of AEU.","name":"copyright","label":"Copyright"}],"article-number":"501918"}}